Wednesday, July 8, 2026

pharma · Colorectal Cancer · Cancer · GDTC

CytoMed Therapeutics

CytoMed Therapeutics clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

1 COMMONWEALTH LANE, U0, SG HQ
2018 Founded
26 Employees
Public company Type
GDTC · NYSE Ticker
Company details
Status
Public
HQ
1 COMMONWEALTH LANE, U0, SG
Founded
2018
Employees
26
Programs
4
Drugs
12
Patents
3
Intelligence · Clinical Programs

CytoMed Therapeutics projects

4 ClinicalTrials.gov programs sponsored by CytoMed Therapeutics.

CytoMed Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Human Umbilical Cord derived MSCs

    CytoMed Therapeutics Ltd

    Lupus Nephritis

    phase 2 mab active

    1 trial
  2. CTM-N2D

    CytoMed Therapeutics Ltd

    Colorectal Cancer

    phase 1 mab active

    1 trial
  3. CTM-N2D-102

    CytoMed Therapeutics Ltd

    Cancer

    phase 1 mab active

    1 trial
  4. human Mesenchymal Stem Cell (MSC) infusion therapy

    CytoMed Therapeutics Ltd

    Aging Well

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does CytoMed Therapeutics have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.